Metvolen XL 50 Tablet is a once-daily extended-release formulation of Metoprolol Succinate, a beta1-selective adrenoceptor blocker indicated for the treatment of hypertension, angina pectoris, and stable left ventricular dysfunction. This tablet is designed to provide a sustained therapeutic effect over a 24-hour period, allowing for a single daily dose to control blood pressure and alleviate symptoms of angina. Metoprolol Succinate, the active ingredient, is a prodrug that is converted to its active form, metoprolol, in the gastrointestinal tract. The extended-release formulation of Metoprolol Succinate is designed to provide a consistent and predictable release of metoprolol over an extended period, thereby minimizing the variability in peak concentrations and duration of action. As a beta-blocker, Metvolen XL 50 Tablet exerts its therapeutic effects by reducing cardiac output, peripheral resistance, and heart rate, while also reducing the release of renin and aldosterone, leading to a decrease in blood pressure.